Last reviewed · How we verify
NCT07416097
Comparison of Multidimensional Parameters in Women With Fibromyalgia and Healthy Controls
NA trial testing Clinical and Questionnaire-Based Assessment in Fibromyalgia in 80 participants. Not yet recruiting.
15 November 2026
Quick facts
| Lead sponsor | Izmir Democracy University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 80 |
| Start date | 15 June 2026 |
| Primary completion | 15 November 2026 |
| Estimated completion | 15 June 2027 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Clinical and Questionnaire-Based Assessment
Conditions studied
- Fibromyalgia — all drugs for Fibromyalgia →
- Chronic Widespread Pain — all drugs for Chronic Widespread Pain →
Sponsor
Izmir Democracy University
Who can join
Adults 18 to 65, female only, with Fibromyalgia or Chronic Widespread Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fibromyalgia (FM) is a chronic, widespread pain syndrome affecting 2-6.6% of the population and significantly impairing quality of life. In addition to pain, individuals with FM commonly experience fatigue, sleep disturbances, cognitive and psychological problems, leading to functional limitations and social difficulties. Central sensitization is considered a key mechanism, although the exact pathophysiology remains unclear, highlighting the need for multidimensional assessment. FM affects not only physical function but also psychological status, autonomic nervous system regulation, sleep quality, self-esteem, eating behaviors, and gastrointestinal function. Depression, anxiety, autonomic dysfunction, sleep disorders, altered eating behaviors, and gastrointestinal symptoms are highly prevalent and closely associated with pain severity, fatigue, and reduced quality of life. Given its complex biopsychosocial nature, FM requires a holistic evaluation and management approach. Accordingly, this study aims to compare symptoms, psychological status, autonomic function, sleep, eating behaviors, and gastrointestinal parameters between women with fibromyalgia and healthy women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07416097
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fibromyalgia
Currently open trials in the same condition.
- NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
- NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
- NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting
Other Izmir Democracy University trials
Trials by the same sponsor.
- NCT07511153 — Does the Cervical Stenosis Affect Hand Function? · not yet recruiting
- NCT07358702 — Sedentary Status and Multidimensional Outcomes in Fibromyalgia · NA · not yet recruiting
- NCT07396597 — Physical Impairments in Premature Ventricular Complex · not yet recruiting
- NCT07474623 — Effects of Nicotine Dependence on Multidimensional Health Outcomes · NA · not yet recruiting
- NCT06996990 — Injury Risk Factors in Volleyball Players · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07416097 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Izmir Democracy University
- Last refreshed: 17 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07416097.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing